Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with Dexrazoxane-Anthracyclines association.
Int J Cardiol
; 299: 271-275, 2020 01 15.
Article
en En
| MEDLINE
| ID: mdl-31422879
ABSTRACT
AIMS:
Cardiovascular disease is a well-recognized cause of increased late morbidity and mortality among survivors of childhood cancer treated with anthracyclines. Co-administration of Dexrazoxane has been shown to significantly reduce short-term and mid-term cardiotoxicity. Aim of this study was to assess cardiac function in long-term (>10â¯years) survivors of childhood tumors treated with dexrazoxane/anthracycline association. METHODS ANDRESULTS:
Twenty cancer survivors previously treated with co-administration of anthracyclines-dexrazoxane for childhood renal tumors or sarcoma and a control group of 20 healthy subjects were enrolled in the study. Echocardiographic measurements included 3D left ventricular (LV) ejection fraction (LVEF) and LV and right ventricular (RV) global longitudinal strain (GLS). Among cancer survivors group the median age at diagnosis was 5â¯years (1-17) and they were evaluated at median follow-up time of 21.5â¯years (10-26). No evidence of cardiac toxicity, as defined by current guidelines, was reported in all survivors. No significant differences in standard and deformation imaging parameters were observed between survivors and controls (3D LVEF 58⯱â¯3% vs 60⯱â¯5% pâ¯=â¯NS; LV GLS -21⯱â¯1% vs -21⯱â¯2% pâ¯=â¯NS; RV GLS -23⯱â¯2% vs -23⯱â¯5% pâ¯=â¯NS). No second tumor was registered in dexrazoxane-treated survivors.CONCLUSIONS:
Our findings may support the role of dexrazoxane as a useful strategy for cardio-protection in children undergoing anthracycline based treatment. However, large randomized trials are needed to confirm the cardio-protective role of dexrazoxane in pediatric setting at long-term follow-up.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Ecocardiografía
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Antraciclinas
/
Dexrazoxano
/
Supervivientes de Cáncer
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Int J Cardiol
Año:
2020
Tipo del documento:
Article